# Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan

> **NCT01410474** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 341 (actual)

## Conditions studied

- Bacterial Meningitis

## Interventions

- **BIOLOGICAL:** Meningococcal ACWY conjugate vaccine

## Key facts

- **NCT ID:** NCT01410474
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2014-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410474, "Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01410474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*